Please login to the form below

Not currently logged in
Email:
Password:

Allergan opens Indian pharma R&D arm

US-headquartered Allergan has opened its first pharmaceutical R&D facility in India

According to local media reports, US-headquartered Allergan has opened its first pharmaceutical R&D facility in India.

The Allergan Pharmaceutical Development Centre India, which will make up part of Allergan's worldwide R&D operations, will focus on implementing global pharmaceutical R&D projects conducted in the region.

According to Scott M Whitcup, Allergan's worldwide executive vice-president of R&D, the centre would have 15 clinical research and data management personnel at the start of operations and could double within two years.

Whitcup said that Allergan's estimated investment for the new centre at USD 3m to USD 5m over the next few years. He added that R&D activities at the centre would initially focus on therapies in areas such as inflammatory and infective conditions of the eye, movement disorders and urological indications.

The centre is Allergan's third largest outside of the US. The company also has Allergan India, which manages the commercial side of Allergan's business there.

8th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?
We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also...
CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...

Infographics